An multicenter,randomized,double blinded,case-control study of pegylatedα-2a plus Ribavirin and TCM in CHC patients

作者：Hongming Nie; Jianjie Chen; Chengbao Wang; Huilin Dong; Qihua lin; Qiming Gong; Yong Zhang; Xiaoyu Hu; Changjian Yin; Guoguang Sheng; Xiaodong Li; Boyu Xue; Lifu Wang; Wenxia Zhao; Xiaorong Chen; Wei Zhang; Yuyong Jiang; Xiaoling Chi; Xiaojun Wang; Qikai Wu; Dewen Mao; Guoxian Lin; Shanzhong Tan; Yuanwang Qiu; Erli Gu; Zhongye Xu

来源：中华医学会第十六次全国病毒性肝炎及肝病学术会议, 中国云南昆明, 2013-06-20.

• CHC
• An multicenter,randomized,double blinded,case-control study of pegylated
• plus Ribavirin and TCM in CHC patients
• TCM

<正>Background Standard therapy for CHC still faces many unmet medical needs.T.C.M.exhibit liver function protection,anti-fibrosis,immune function modulation and some extent anti-viral function in CHC treatment, particularly,reduce medicine's adverse events and increase patients'adherence.Aim of this study is to explore synergistic effect of T.C.M.combined with standard therapy in CHC treatment.Methods This was a

• 出版日期2013
• 单位河南大学; 上海大学; 上海交通大学; 南京大学